Proposed Benchmark for Evaluating DNA Sequence Analysis Established by an International External Quality Assessment Scheme

Background: In the past 15 years clinical laboratory science has been transformed by the use of technologies that cross the traditional boundaries between laboratory disciplines. However, during this period, issues of quality have not always been given adequate atten-tion. The European Molecular Genetics Quality Network (EMQN) has developed a novel external quality assessment scheme for evaluation of DNA sequencing. We report the results of an international survey of the quality of DNA sequencing among 64 laboratories from 21 countries. Methods: Current practice for DNA sequence analysis was established by use of an online questionnaire. Participating laboratories were provided with 4 DNA samples of validated genotype. Evaluation of the results included assessing the quality of sequence data, variant genotypes, and mutation nomenclature. To accommodate variations in mutation nomenclature, variants indicated by participants were scored for compliance with 3 acceptable marking schemes. Results: A total of 346 genotypes were analyzed. Of these, 19 (5%) genotyping errors were made. Of these, 10 (53%) were false-negative and 9 (47%) were false-positive results. A further 27 (8%) errors were made in naming mutations. Results were analyzed for 3 indicators of data quality: PHRED quality scores, Quality Read Length, and Quality Read Overlap. Most laboratories produced results of acceptable diagnostic quality as judged by these indicators. The results were used to calculate a consensus benchmark for DNA sequencing against which individual laboratories could rank their performance. Conclusions: We propose that the consensus benchmark can be used as a baseline against which the aggregate and individual laboratory standard of DNA sequencing may be tracked from year to year. that assessment (EQA) 1 for 3 criteria (correct assign-ment and the mutation effect) for each allele. The total score for each the

[1]  E. Dequeker,et al.  Towards quality assurance and harmonization of genetic testing services in the European Union , 2004, Nature Biotechnology.

[2]  M. Burns,et al.  Generic scheme for independent performance assessment in the molecular biology laboratory. , 2004, Clinical chemistry.

[3]  D. Stoppa-Lyonnet,et al.  External quality assessment for mutation detection in the BRCA1 and BRCA2 genes: EMQN's experience of 3 years. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  Mario Pazzagli,et al.  External quality assurance program for PCR amplification of genomic DNA: an Italian experience. , 2003, Clinical chemistry.

[5]  A. V. van Loon,et al.  European Proficiency Testing Program for Molecular Detection and Quantitation of Hepatitis B Virus DNA , 2001, Journal of Clinical Microbiology.

[6]  W. Grody,et al.  Quality control in molecular genetic testing , 2001, Nature Reviews Genetics.

[7]  Clemens R. Müller,et al.  Quality control in mutation analysis: the European Molecular Genetics Quality Network (EMQN) , 2001, European Journal of Pediatrics.

[8]  E. Dequeker,et al.  Genetic testing and quality control in diagnostic laboratories , 2000, Nature Genetics.

[9]  M. Neumaier,et al.  Experiences with External Quality Assessment (EQA) in Molecular Diagnostics in Clinical Laboratories in Germany , 2000, Clinical chemistry and laboratory medicine.

[10]  S. Kitchen,et al.  A UK National External Quality Assessment Scheme (UK Neqas) for Molecular Genetic Testing for the Diagnosis of Familial Thrombophilia , 1999, Thrombosis and Haemostasis.

[11]  W. Geilenkeuser,et al.  External Quality Assessment of Molecular Biology-Based Methods Used in Laboratories of Clinical Chemistry and Human Genetics , 1998, Clinical chemistry and laboratory medicine.